Zero Point Five Therapeutics
Baltimore, US · Founded 2018 · District of Columbia corporation · 3 known investors
Founders & leadership
JA
Joseph Amprey IIINamed on SEC filing
Board
JJ
BA
Ben AuspitzBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$11.5M disclosed across 2 rounds · 2023–2025
▶$4.3MraisedApr 2025 · 10 investors · BiotechnologyRule 506(b)
▶$4.3MraisedApr 2025 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ben AuspitzDirector
- Joseph Amprey IIIExecutive Officer, Director
- Jodi JahicDirector
- Offering amount
- $5.3M
- Amount sold
- $4.3M
- First sale
- Apr 2025
- Incorporated
- Corporation, District Of Columbia
- Federal exemptions
- 06b
▶$7.2MraisedJul 2023 · 15 investors · BiotechnologyRule 506(b)
▶$7.2MraisedJul 2023 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jodi JahicDirector
- Joseph Amprey IIIExecutive Officer, Director
- Ben AuspitzDirector
- Offering amount
- $10.1M
- Amount sold
- $7.2M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Zero Point Five Therapeutics's investors?
- Zero Point Five Therapeutics's investors include Portfolia, Aligned Partners, TEDCO.
- How much funding has Zero Point Five Therapeutics raised?
- Zero Point Five Therapeutics has disclosed $11.5M raised across 2 rounds.
- Where is Zero Point Five Therapeutics headquartered?
- Zero Point Five Therapeutics is headquartered in Baltimore, US.